Nutex Health (NASDAQ:NUTX) Trading 10.3% Higher – Should You Buy?
by Scott Moore · The Cerbat GemNutex Health Inc. (NASDAQ:NUTX – Get Free Report) traded up 10.3% during trading on Thursday . The stock traded as high as $130.10 and last traded at $131.8130. 68,978 shares traded hands during trading, a decline of 63% from the average session volume of 188,765 shares. The stock had previously closed at $119.45.
Wall Street Analysts Forecast Growth
Several research analysts have recently commented on the company. Wall Street Zen upgraded Nutex Health from a “hold” rating to a “buy” rating in a research note on Saturday, May 9th. Weiss Ratings raised Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Monday, May 4th. One analyst has rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $205.00.
Read Our Latest Stock Analysis on Nutex Health
Nutex Health Stock Performance
The firm has a market capitalization of $925.29 million, a price-to-earnings ratio of 10.39 and a beta of 0.25. The company has a fifty day moving average of $110.70 and a two-hundred day moving average of $127.52. The company has a debt-to-equity ratio of 0.66, a quick ratio of 3.12 and a current ratio of 3.14.
Nutex Health (NASDAQ:NUTX – Get Free Report) last released its quarterly earnings results on Thursday, April 30th. The company reported $6.52 earnings per share for the quarter, topping the consensus estimate of $3.99 by $2.53. The business had revenue of $216.49 million during the quarter, compared to analysts’ expectations of $227.80 million. Nutex Health had a return on equity of 23.50% and a net margin of 10.95%.
Hedge Funds Weigh In On Nutex Health
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Islay Capital Management LLC acquired a new position in Nutex Health in the 4th quarter valued at $34,000. BNP Paribas Financial Markets raised its holdings in Nutex Health by 966.7% in the 2nd quarter. BNP Paribas Financial Markets now owns 320 shares of the company’s stock valued at $40,000 after acquiring an additional 290 shares in the last quarter. Royal Bank of Canada raised its holdings in Nutex Health by 752.4% in the 4th quarter. Royal Bank of Canada now owns 358 shares of the company’s stock valued at $59,000 after acquiring an additional 316 shares in the last quarter. Osaic Holdings Inc. raised its holdings in Nutex Health by 280.3% in the 4th quarter. Osaic Holdings Inc. now owns 810 shares of the company’s stock valued at $133,000 after acquiring an additional 597 shares in the last quarter. Finally, EverSource Wealth Advisors LLC acquired a new position in Nutex Health in the 1st quarter valued at $83,000. 5.32% of the stock is owned by institutional investors and hedge funds.
About Nutex Health
Nutex Health, Inc (NASDAQ: NUTX) is an integrated outpatient healthcare services company based in San Antonio, Texas. The company focuses on delivering a range of ambulatory care solutions, including urgent care, telemedicine, medical imaging, teleradiology, weight‐loss services and behavioral health support. By combining in‐person clinics with virtual care capabilities, Nutex Health aims to provide patients with accessible, cost‐effective treatment options outside traditional hospital settings.
The company’s urgent care network operates through both standalone and retail‐anchored centers, offering treatment for non‐life‐threatening injuries and illnesses, preventive screenings and basic primary care.